The Biotech Advisory Panel is a panel of experienced participants in the biotech industry formed for the purpose of providing advice relating to biotech companies. The function of the members of the Panel is advisory only and members will be consulted (by the Exchange, the Listing Committee or the SFC) on an individual and “as needed” basis. The Exchange will be able to consult the Biotech Advisory Panel from time to time for assistance when reviewing listing applications, including prospectus disclosure, and assessing the suitability (including sustainability) of biotech companies applying for a listing under Chapter 18A. Members of the Biotech Advisory Panel are appointed for an initial term of two years which may be extended by mutual agreement.
A list of the initial members of the Biotech Advisory Panel is set out below. The Exchange will look to include additional members as appropriate.